Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Innovative Medical Detox Treatment for Fentanyl Clinically Shown to Reduce Opioid Withdrawal Symptoms, Treatment Duration

Gallus Medical Detox Centers' new accelerated micro induction treatment protocol addresses significant increase in fentanyl use; fear of pain associated with opioid withdrawal


News provided by

Gallus Medical Detox Centers

Aug 12, 2021, 09:00 ET

Share this article

Share toX

Share this article

Share toX


DENVER, Aug. 12, 2021 /PRNewswire-PRWeb/ -- Gallus Medical Detox Centers (Gallus), a national leading inpatient drug and alcohol medical detox services provider, announces today the launch of a new inpatient medical detoxification protocol for fentanyl that has been clinically shown to reduce withdrawal symptoms, shorten treatment time and help patients successfully detox in order to transition to treatment and long-term recovery.

Patients using the new accelerated micro induction (AMI) protocol for opioid use disorder (OUD) with fentanyl reported a significantly lower Clinical Opiate Withdrawal Scale score (COWS), an 11-item scale designed to help clinicians determine the severity of opiate withdrawal (1). Gallus found that the new treatment process lowered COWS scores an average of 4.4 points, or 42% a day, over the three days prior to full induction. Patient treatment time was also reduced by 15%.

The results of this new fentanyl detox program are ground breaking, as it addresses many of the concerns patients have in starting their journey to lifelong recovery.

Post this

"The results of this new fentanyl detox program are ground breaking, as it addresses many of the concerns patients have in starting their journey to lifelong recovery," says Shannon Weir, RN, Director of Clinical Education and Quality Assurance at Gallus. "Continuous improvement of our evidence-based medical detox protocols, combined with an ongoing commitment to prepare patients for aftercare treatment, provides a solid foundation for recovery."

In addition to the Gallus Method achieving dramatic improvement in managing withdrawal symptoms, new patient research is showing a clinically and statistically significant decrease in depression, an average drop of 5.88 points, during inpatient medical detox treatment as measured using the PHQ-9.

Currently, Gallus' rate of patient transition to aftercare is 85%, as compared to estimates of 15% when detox services are provided in a hospital setting. This new AMI protocol is expected to increase the number of patients who enter OUD treatment as well as aftercare.

"Gallus' decade of medical experience and front-line exposure to evolving SUD trends affords us the unique ability to focus on continually improving treatment outcomes," said Doug Weiss, President & CEO of Gallus. "By using our expertise and knowledge of how substances impact our patients, we can fulfill our commitment to excellence in providing patients with safe, comfortable and effective medical detox treatment as the first step in their recovery journey."

Gallus Medical Detox Centers' evidence-based medical detox services for substance use disorders include alcohol, opioid, benzodiazepines, stimulants, polysubstance and others. It also has the expertise to treat patients with acute substance use disorders and co-occurring mental health or chronic physical conditions.

The Gallus AMI treatment protocol is being offered at its locations in Scottsdale, Arizona and Littleton, Colorado. For those who are seeking professional help to treat a substance use disorder, please visit gallusdetox.com or call 888-306-3122 for Admissions. Gallus also offers community updates and alerts on substance use trends through The Pulse, a newsletter available on the website.

(1) Clinical Opiate Withdrawal Scale (drugabuse.gov)

About Gallus Medical Detox Centers
A national Center of Excellence, Gallus Medical Detox Centers provide the highest quality inpatient medical detox services using evidence-based IV medication protocols that avoid cross-addiction, delivered by highly trained medical staff, in a safe, comfortable and private patient environment that optimizes treatment outcomes.

With locations in Arizona and Colorado, Gallus' vision is to be the best, first step in overcoming substance use disorders for patients needing medical detox and to lead the field in the science, education, training and customer experience. Through the Gallus Method, patients receive unique, personalized and 24-hour care delivered in a professional, safe and peaceful environment to achieve an optimal physiological withdrawal experience that will move them into behavioral health therapy and ultimately find long-term recovery.

Media Contact

Gallus Communications, Gallus Medical Detox Centers, +1 (239) 297-6592, [email protected]

SOURCE Gallus Medical Detox Centers

Related Links

https://www.gallusdetox.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.